Evidence map›Paper›PMID 41034790›Full record

ArticleBMC cancer2025

Non-specific uptake of

Liu Xiao, Liu Yang, Lin Li, Wenjie Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liu Xiao *Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan province, P.R. China.
Liu Yang *Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan province, P.R. China.
Lin LiDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan province, P.R. China. lilinhuaxi@sina.com.
Wenjie ZhangDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan province, P.R. China. zhang_wenjie@scu.edu.cn.

Funding

1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University ZYGD23016China Postdoctoral Science Foundation 2024M752257Natural Science Foundation of Sichuan Province, China 2025ZNSFSC1761
6 · The paper itself

Abstract

purposeThis study aims to analyze the characteristics of non-specific uptake(NSU) of MATERIALS: This retrospective study included 122 patients who underwent

resultsA total of 122 patients were included in the final analysis, comprising 42 patients with pancreatic NSU and 80 patients without NSU. The SUVmax was 7.94 ± 5.39 and 2.01 ± 0.50 in NSU and non-NSU group respectively on

conclusionPancreatic diffuse NSU is associated with the presence of diabetes, lower hematocrit levels, and higher CRP levels. These findings may assist clinicians and nuclear medicine physicians in interpreting imaging appearances, helping to avoid misdiagnosis.

Indexed as

Gallium RadioisotopesPancreasPancreatic NeoplasmsPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesROC CurveGallium RadioisotopesRadiopharmaceuticals68Ga-FAPINon-specific uptakePancreasPET/CT

Identifiers

PMID41034790
PMCPMC12487178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.